B

Brainsway Ltd
TASE:BWAY

Watchlist Manager
Brainsway Ltd
TASE:BWAY
Watchlist
Price: 1 808 ILS -2.53% Market Closed
Market Cap: 594m ILS
Have any thoughts about
Brainsway Ltd?
Write Note

Brainsway Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Brainsway Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Brainsway Ltd
TASE:BWAY
Cash & Cash Equivalents
$46m
CAGR 3-Years
39%
CAGR 5-Years
39%
CAGR 10-Years
16%
Nano-X Imaging Ltd
NASDAQ:NNOX
Cash & Cash Equivalents
$56.4m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inmode Ltd
NASDAQ:INMD
Cash & Cash Equivalents
$403.4m
CAGR 3-Years
49%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Cash & Cash Equivalents
$70.2m
CAGR 3-Years
-18%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Cash & Cash Equivalents
$24.4m
CAGR 3-Years
110%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Cash & Cash Equivalents
$15.6m
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Brainsway Ltd
Glance View

Market Cap
594m ILS
Industry
Health Care

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

BWAY Intrinsic Value
2 161.92 ILS
Undervaluation 16%
Intrinsic Value
Price
B

See Also

What is Brainsway Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
46m USD

Based on the financial report for Dec 31, 2023, Brainsway Ltd's Cash & Cash Equivalents amounts to 46m USD.

What is Brainsway Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
16%

Over the last year, the Cash & Cash Equivalents growth was -3%. The average annual Cash & Cash Equivalents growth rates for Brainsway Ltd have been 39% over the past three years , 39% over the past five years , and 16% over the past ten years .

Back to Top